-
2-ethoxy-1-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl](2H4)phenyl}methyl)-1H-1,3-benzodiazole-7-carboxylic acid
-
ChemBase ID:
163592
-
Molecular Formular:
C24H20N6O3
-
Molecular Mass:
440.454
-
Monoisotopic Mass:
440.15968853
-
SMILES and InChIs
SMILES:
c1ccc(c2c1nc(n2Cc1ccc(cc1)c1ccccc1c1[nH]nnn1)OCC)C(=O)O
Canonical SMILES:
CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1nnn[nH]1)c(ccc2)C(=O)O
InChI:
InChI=1S/C24H20N6O3/c1-2-33-24-25-20-9-5-8-19(23(31)32)21(20)30(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-26-28-29-27-22/h3-13H,2,14H2,1H3,(H,31,32)(H,26,27,28,29)
InChIKey:
HTQMVQVXFRQIKW-UHFFFAOYSA-N
-
Cite this record
CBID:163592 http://www.chembase.cn/molecule-163592.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
2-ethoxy-1-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl](2H4)phenyl}methyl)-1H-1,3-benzodiazole-7-carboxylic acid
|
|
|
IUPAC Traditional name
|
2-ethoxy-3-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl](2H4)phenyl}methyl)-1,3-benzodiazole-4-carboxylic acid
|
|
|
Synonyms
|
2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl)[1-(phenyl-d4)-1’-phenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid
|
CV-11974-d4
|
Candesartan M1-d4
|
3-[[2'-(1H-Tetrazol-5-yl)[1-(phenyl-d4)-1’-phenyl]-4-yl]methyl]-2-ethoxy-3H-benzimidazole-4-carboxylic Acid
|
Candesartan-d4
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
Data Source
|
Data ID
|
Price
|
TRC
|
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
2.9523642
|
H Acceptors
|
7
|
H Donor
|
2
|
LogD (pH = 5.5)
|
1.0018892
|
LogD (pH = 7.4)
|
-0.40843076
|
Log P
|
4.4107194
|
Molar Refractivity
|
134.9175 cm3
|
Polarizability
|
49.003094 Å3
|
Polar Surface Area
|
118.81 Å2
|
Rotatable Bonds
|
7
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
TRC
Toronto Research Chemicals -
C175578
|
Labelled Candesartan, an angiotensin II type-1 receptor antagonist. Used in treatment of congestive heart failure. Antihypertensive. |
PATENTS
PATENTS
PubChem Patent
Google Patent